View publications by title beginning with...
By Health Topic
View publications by health topic
Your selection has returned 9 publications:
Use of tobacco, alcohol, and over-the-counter and illicit substances among Indigenous students participating in the Australian Secondary Students Alcohol and Drug Survey 2008
In addition to the main 2008 Australian Secondary Students Alcohol and Drug (ASSAD) Survey, students from an additional 19 schools from rural areas in Western Australia, Queensland, South Australia and the Northern Territory were surveyed. From the 400 schools surveyed as part of the 2008 ASSAD and ASSAD Extension, 1317 students identified themselves as Indigenous Australians. This report is based on data from this combined group of Indigenous students.
The National Amphetamine-Type Stimulant Strategy 2008-2011 (the Strategy) has been developed within the existing legislative framework and focuses on prevention, supply reduction and treatment in a partnership framework.
Monograph Series No. 69 - This background paper is a companion paper to the National Amphetamine-Type Stimulant Strategy 2008-2011, and describes the goals and objectives of the Strategy and the priority areas for action. It was prepared to provide greater insight into the Strategy for researchers and other interested parties.
This report explores awareness, attitudes, perceptions and experience of issues relating to illicit drug use and mental illness amongst youth, young adults, their parents and the broader community.
This page contains links to the publication 'The Prevention of Substance Use, Risk and Harm in Australia - a review of the evidence'.
This resource provides an overview of key health and medical issues arising from the use of alcohol and other drugs.
In its concern with preventing the transmission of the hepatitis C virus (HCV), this research report examines Australia’s efforts to date in prevention education particularly among people who inject drugs.
THIS DOCUMENT HAS BEEN RESCINDED: Acknowledgements for assistance in the preparation of this manuscript.
THIS DOCUMENT HAS BEEN RESCINDED: National Drug Strategy Monograph Series No. 25.